western markets

Hi all,

I only check this forum occasionally, but have a stake in PLT. I am wondering why the company has chosen a stategic approach to engage emerging nations (where to compete there must be low per unit cost, but high product turnover) as opposed to entering western markets where there can be lower unit turnover, but higher expect RRP for each product (therefore less strain on manufacturing for a similar profit).

I see the logic from the idea of higher per unit sales, but the demand on manufacturing has to be a challenge in the emerging nations (esp if there is still teething issues). Would be nice if PLT could start moving into western markets since (the last I heard) the manufaturing process is supposed to be reasonably past it's QA problems.

The UK (for example) has many business's (and entrenprenours) who have set up successful business's of simply reselling products.... which are all made in China or India. I think PLT is in a prime position to engage that sort of market if it exports it's products from the chinese manufacturing line and into the UK (or from poland when that is properly online).

In western markets, there is higher knowledge of the screening in the general community. Having lived in india a few years ago there is bugger all knowledge on womens health from what I could ascertain (I presume this may be similar in china - another high populous community). So demand won't come from the population - only the govt's and distributors pushing the product. Conversely as western communities show better promise for demand sourced from the end-patients as well as distrbutors seeking sales (my humble view anyway).

BTW - Funny I should mention UK actually - the UK media is going estatic over an ex-Big Brother star (Jade Goody) having contracted Cervical cancer with media frequently campaigning for increased PAP smear awareness.... nice time to introduce PLT's Truescreen product.

Be interested in your views

rgds - dap